Platelet - most related articles:
- Nplate bone marrow stimulator approved to treat low platelet counts
- Champion clinical trial program of cangrelor discontinued
- 812 cases of dengue fever in Delhi
- SMS reminders about heart medication improved patient adherence
- Genetic factors may predict depression in heart disease patients
Platelet articlesNew antiplatelet drug Kengreal approved by US FDA
The U.S. Food and Drug Administration approved Kengreal (cangrelor), an intravenous antiplatelet drug that prevents formation of harmful blood clots in the coronary arteries, the blood vessels that supply blood to the heart.Blood stem cells longevity mechanism discovered
The blood stem cells that live in bone marrow are at the top of a complex family tree. Such stem cells split and divide down various pathways that ultimately produce red cells, white cells and platelets. These "daughter" cells must be produced at a rate of about one million per second to constantly replenish the body's blood supply.SMS reminders about heart medication improved patient adherence
Getting reminder texts helped patients take their heart medicines (anti-platelet and cholesterol-lowering drugs) more regularly, according to research presented at the American Heart Association's Scientific Sessions 2013.4 drugs accounted for two thirds of emergency hospitalizations in US
Handful of drugs are responsible for most emergency room visits by patients in US, revealed by CDC researchers (US Centers for Disease Control and Prevention) in a recent study.Heparin sodium allergy may lead to thrombocytopenia
A serious side-effect of heparin is heparin-induced thrombocytopenia (HIT). HIT is caused by an immunological reaction that makes platelets a target of immunological response, resulting in the degradation of platelets.Synthetic platelets halve clotting time, halt bleeding
Blood loss is a major cause of death from roadside bombs to freeway crashes. Traumatic injury, the leading cause of death for people age 4 to 44, often overwhelms the body's natural blood-clotting process.Gene variant linked to effectiveness of plavix
Patients with a certain genetic variation and who received the antiplatelet drug clopidogrel -- Plavix -- had a decreased platelet response to treatment, revealed by researchers.Champion clinical trial program of cangrelor discontinued
The Medicines Company (NASDAQ: MDCO) announced that it is discontinuing its Phase 3 CHAMPION clinical trial program of cangrelor in patients undergoing percutaneous coronary intervention (PCI).FDA will review Daiichi Sankyo, Lilly drug Prasugrel for heart attack
Daiichi Sankyo Company, Limited (TSE: 4568) and Eli Lilly and Company (NYSE: LLY) confirmed that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) will review prasugrel during an advisory committee hearing on February_3, 2009.Nplate bone marrow stimulator approved to treat low platelet counts
The U.S. Food and Drug Administration approved Nplate (romiplostim), the first product that directly stimulates the bone marrow to produce needed platelets in patients with a rare blood disorder that can lead to serious bleeding.Prasugrel cuts risk of stent-related clots
The investigational antiplatelet drug prasugrel plus aspirin produced a marked and highly statistically significant reduction in the risk of coronary stent thrombosis (ST) - a major concern for physicians and patients with potentially fatal consequences - in patients who received a stent as compared to standard therapy with clopidogrel (Plavix) plus aspirin, according to a stent analysis from the head-to-head TRITON-TIMI 38 trial.Aspirin resistance increases heart attack, stroke risk
Being resistant to aspirin makes patients four times more likely to suffer a heart attack, stroke or even die from a pre-existing heart condition, according to a study published in British Medical Journal, UK. The study relates to patients who are prescribed aspirin long term as a way of preventing clots from forming in the blood.
12 Platelet articles listed above.
List health news
, Health organizations
, Health news world
, Glossary Go to top
The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
© 2015 HealthNewstrack.com
Health Newstrack - Track Health News Daily at HealthNewstrack.com. Our Newstrack on Health News provides latest health news, medical news, and health articles with recent health & medical updates.